Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
That's interesting Chippy - in early June I had PCR's on successive days - the first was 'cursory' and proved positive but the second, 'polish to brain stem', proved negative !
Testing in RSA may have been unreliable but the results in Europe are accurate and we MAY have a problem - but let's hope Omicron is a 'damp squib'. ATB
TF, having travelled continuously throughout the pandemic one thing stands out. The testing has a massive difference in technique with some trying to polish your brain stem with the stick to others giving a cursory tickle. Factor in Africa where you can pay a little extra for a good result and your bound to get this happening. LFT on arrival should have been implemented but the only inconvenience at LHR was the immigration queues just to make sure you lingered with the most people as possible before leaving the airport.
Re. the 60 positives among the 600 PAX from RSA at Schipol - 13 have been found (so far) to have the Omicron variant - was it spreading on the planes ? (in which case 'only' 13 is surprising). Were PAX 72 hour tested before boarding ? The alarming point for me is the 10% positives overall.
We just don't know much about Omicron yet - hopefully it'll transpire to be a 'damp squib' as some have suggested . . .
Omicron infections are going to be hard to find if the symptoms are different and maybe milder . . . it could be spreading like wildfire, or not. In this DM piece, about the 5th graphic down shows the mutations including those to the nucleocapsid - it'll be interesting to find out if 'Covidity 1' protects against omicron or if a 'Covidity 2' will be needed ? https://www.dailymail.co.uk/news/article-10251469/Britain-records-case-Omicron-coronavirus-variant.html
Also in the DM, another tragic story of an anti-vaxxer dying of Covid - I have a Friend, 60, an ex-Fireman who keeps himself in peak condition with breathing exercises, vitamin D etc., who describes himself as a wait and see, 'vax wise' - he proudly wouldn't even look at a recent Guardian article about unvax deaths. I wish him well . . . .
Dragon agree, this coming week could be very interesting indeed.
Noted WTPs post re another new position, seems to me we are preparing ourselves for what should be a very lucrative licensing deal in the not so distant future. Very interesting times
If they find a US case during today, it's going to be very nasty!
Hi BOJO
For the true value of Covidity to be known the 40 subjects will need to circulate in the general population and be infected by Covid19. Only when that has happened to several in the group will they be able to statistically project the % of cover and any protection given against Omicron. If by Christmas they can analyse many blood samples they will be able to see the effects Covidity is having on the Spike and the Nucleocapsid. If these are very positive then surely Scancell can seek extra backing to step up the whole trial process.
You would hope so !
Chester.
As the world markets focus will be on covid vaccines from tomorrow it will be very interesting to watch some of the posters comments on here, I fell some will show their true Colors in the next few days.
Yes Chester,
I agree. Maybe it’s because Scancell have always been slow and steady that I base my feeling it may wait. On the other hand, considering the current financial footing and its ability to work more so in-house, it could be they are able to be bold with COVIDITY. Especially so if the data makes a persuasive case. By ‘bold,’ I am not trying to infer reckless. Confident maybe; an admirable attribute.
ATB
Hi BOJO2020
I am just pondering the question of whether Scancell have to keep all their ongoing findings under wraps or can they indicate any positive findings, or at the very least appraise the UK Government of the potential. It would be very stupid to allow a large biotech from another country to swoop in, gain control and then sell the vaccine to the US or elsewhere. Surely a working 2nd Gen. Universal Vaccine should be backed by our own government money to keep it as a UK success.
I realise trials have to run their course but under these pandemic circumstances non-life threatening short cuts should be pursued.
Chester.
Chester,
I am looking at April/May 22 for some indication although I am sure the timelines may slip slightly. As that is such a short time, maybe Lindy would be minded to wait until the spring anyway and make doubly sure.
Not sure if you read about Merck’s covid pill? Early data is not always what it seems.
https://www.biopharmadive.com/news/merck-molnupiravir-final-results-covid/610597/
Personally I think targeting of the N protein will prove positive and alert the market that Scancell is a serious proposition.
ATB
Lets suppose that all 40 trial subjects have been recruited since FPD on the 5th October. Second dose after 29 days = early November.
Questions : If all 40 have received their 2nd doses by end November, When would Scancell know internally that the Antibodies are attaching to the spike proteins as expected and When would they be able to detect the emergence of 'T' Cells targeting infected Cells ?
The full trial is over 6 months meaning the official read out would be April / May, but as with the Oxford Vaccine could the data be 'part read' early ?
Chester.
Pfizer and Astra are saying sure we can have a vax that can whack this new variant in 100 days..... yeah well then that needs mass manufacturing and shipping out then administrating to people who might have only just had their booster....the logistics and costs are massive and then comes along a new escape the new vax variant.... So let us see how this latest variant performs but it surely shows the need for better long term broader protection vaccines... not to rely just on the first gens being tweaked every time a new variant of concern arises
Great post Roses,
We know that sooner or later we will have a virus mutation of real concern. We need to be ready and presently COVIDITY and other 2nd Gen vaccines look like the way to go. Wether Omicron turns out to be a serious as some fear we will have to wait and see, however it is a timely reminder that the virus will mutate. That’s why we need to vaccinate the whole world and that means there is room in that market for all on different timelines and price points.
ATB
Covid in general affects most people with mild to no symptoms it is the few per cent for who that that is not the case as we know those are the ones that then go on to end up in the hospital and put a huge burden on the health care system... If this new variant can infect a significantly higher number of double even triple vaxed and already previously infected then it is likely it will impact the health system in a significant manner... an almost back to square one scenario with vaccine makers rushing to catch up.... the whack a mole approach where an already broadly protective and effective vaccine is if you like already future proof to the next variant...
Storm in a tea cup or not, it shows how easily and quickly the virus can mutate and as a lot of virologists have publicly stated - it is a matter of ‘when’ not ‘if’ the virus mutates to a version that the current vaccines can not deal with.
That is why vaccines such as scancell’s will become more and more important as the weeks and months go by.
It looks like a storm in a teacup! Media and governments overreacting…
Currently the existing vaccines are working to a reasonable degree and better than the current flu vaccine efficacy…
Omicron is causing Very mild symptoms so far…and I haven’t heard of any hospital admissions or death yet….but one could argue it’s too early to know and I agree on this too but so far no severe symptoms were reported.
Covidity result of the P1 is on safety is coming in H1 as per Company…earlier indications of other blood parameters will be less significant for SP but may increase the appetite for a bigger pharma…
Covidity P2 efficacy results late 2022 if we are lucky but more likely 2023…
Better focus on all over picture including other equally valuable of sclp other products and corporate actions.
Holding strong but not adding…
Take advantage of the other sectors bargain shares at the mean time for a quick profits…
This panic in stock markets and oil price will be short lived…
If sclp sp spikes..then I will be ready to sell a few and re enter at lower…all just imo.
GL